LUCI DAVID P

Director at ACCESS PHARMACEUTICALS INC · on record since Jan 8, 2007
Director at MACROCHEM CORP · on record since Apr 24, 2008
Pres. & Chief Business Officer at MACROCHEM CORP · on record since Apr 24, 2008
10% owner at Acurx Pharmaceuticals, Inc. · on record since Jun 24, 2021
Director at Acurx Pharmaceuticals, Inc. · on record since Apr 22, 2026
President and CEO at Acurx Pharmaceuticals, Inc. · on record since Apr 22, 2026
Director at Dipexium Pharmaceuticals, Inc. · on record since Mar 19, 2014
President, CEO, Secretary at Dipexium Pharmaceuticals, Inc. · on record since Mar 19, 2014
10% owner at Dipexium Pharmaceuticals, Inc. · on record since Mar 19, 2014
Director at SPATIALIZER AUDIO LABORATORIES INC · on record since Feb 14, 2018
CFO, General Counsel at BIOENVISION INC · on record since Aug 12, 2005

Insider trading activity of LUCI DAVID P

Transactions on record: 60; since Nov 25, 2003

Open-market buys: 9; $177K

Open-market sells: 4; $1.6M

Companies traded: 6; last filing Apr 22, 2026

Figures computed from official regulatory filings — methodology.

Companies where LUCI DAVID P has traded

Acurx Pharmaceuticals, Inc.14 tx · $220.3K · Apr 22, 2026
SPATIALIZER AUDIO LABORATORIES INC2 tx · Aug 22, 2018
Dipexium Pharmaceuticals, Inc.6 tx · $777.8K · Apr 21, 2017
ACCESS PHARMACEUTICALS INC11 tx · $247.2K · Nov 2, 2009
MACROCHEM CORP2 tx · $1.8K · Apr 24, 2008
BIOENVISION INC25 tx · $3.9M · Jul 12, 2007

Track record of LUCI DAVID P

Statistical track record

Free

Open-market buys: 14

Last buy: Jan 6, 2025

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of LUCI DAVID P

Co-insiders of LUCI DAVID P

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Acurx Pharmaceuticals, Inc.	Apr 22, 2026	AwardD	37,100	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Feb 6, 2025	AwardD	250,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jan 8, 2025	Buy	49,261	1.02 USD	$50.2K	SEC
Acurx Pharmaceuticals, Inc.	Jan 8, 2025	BuyD	49,261	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Apr 3, 2024	AwardD	250,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jan 4, 2024	ExerciseD	-19,737	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jan 4, 2024	Exercise	19,737	3.55 USD	$70.1K	SEC
Acurx Pharmaceuticals, Inc.	Feb 24, 2023	AwardD	130,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 29, 2022	BuyD	19,737	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 29, 2022	BuyD	19,737	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 29, 2022	Buy	19,737	3.80 USD	$75K	SEC
Acurx Pharmaceuticals, Inc.	Nov 22, 2021	Buy	5,200	4.80 USD	$25K	SEC
Acurx Pharmaceuticals, Inc.	Jul 6, 2021	AwardD	500,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 6, 2021	AwardD	350,000	0.00 USD	$0	SEC
SPATIALIZER AUDIO LABORATORIES INC	Aug 22, 2018	AwardD	15,000	0.00 USD	$0	SEC
SPATIALIZER AUDIO LABORATORIES INC	Aug 22, 2018	AwardD	150,000	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Apr 21, 2017	OtherD	-298,826	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Apr 21, 2017	AwardD	275,000	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Jan 21, 2016	AwardD	35,000	10.16 USD	$355.6K	SEC
Dipexium Pharmaceuticals, Inc.	Jan 29, 2015	AwardD	35,000	11.35 USD	$397.3K	SEC
Dipexium Pharmaceuticals, Inc.	Mar 19, 2014	AwardD	298,826	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Mar 19, 2014	Buy	2,083	12.00 USD	$25K	SEC
ACCESS PHARMACEUTICALS INC	Nov 2, 2009	AwardD	20,000	1.38	$27.6K	SEC
ACCESS PHARMACEUTICALS INC	Nov 2, 2009	AwardD	6,000	2.90	$17.4K	SEC
ACCESS PHARMACEUTICALS INC	Nov 2, 2009	BuyD	2.5	10,000.00	$25K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Acurx Pharmaceuticals, Inc.	Apr 22, 2026	AwardD	37,100	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Feb 6, 2025	AwardD	250,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jan 8, 2025	Buy	49,261	1.02 USD	$50.2K	SEC
Acurx Pharmaceuticals, Inc.	Jan 8, 2025	BuyD	49,261	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Apr 3, 2024	AwardD	250,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jan 4, 2024	ExerciseD	-19,737	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jan 4, 2024	Exercise	19,737	3.55 USD	$70.1K	SEC
Acurx Pharmaceuticals, Inc.	Feb 24, 2023	AwardD	130,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 29, 2022	BuyD	19,737	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 29, 2022	BuyD	19,737	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 29, 2022	Buy	19,737	3.80 USD	$75K	SEC
Acurx Pharmaceuticals, Inc.	Nov 22, 2021	Buy	5,200	4.80 USD	$25K	SEC
Acurx Pharmaceuticals, Inc.	Jul 6, 2021	AwardD	500,000	0.00 USD	$0	SEC
Acurx Pharmaceuticals, Inc.	Jul 6, 2021	AwardD	350,000	0.00 USD	$0	SEC
SPATIALIZER AUDIO LABORATORIES INC	Aug 22, 2018	AwardD	15,000	0.00 USD	$0	SEC
SPATIALIZER AUDIO LABORATORIES INC	Aug 22, 2018	AwardD	150,000	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Apr 21, 2017	OtherD	-298,826	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Apr 21, 2017	AwardD	275,000	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Jan 21, 2016	AwardD	35,000	10.16 USD	$355.6K	SEC
Dipexium Pharmaceuticals, Inc.	Jan 29, 2015	AwardD	35,000	11.35 USD	$397.3K	SEC
Dipexium Pharmaceuticals, Inc.	Mar 19, 2014	AwardD	298,826	0.00 USD	$0	SEC
Dipexium Pharmaceuticals, Inc.	Mar 19, 2014	Buy	2,083	12.00 USD	$25K	SEC
ACCESS PHARMACEUTICALS INC	Nov 2, 2009	AwardD	20,000	1.38	$27.6K	SEC
ACCESS PHARMACEUTICALS INC	Nov 2, 2009	AwardD	6,000	2.90	$17.4K	SEC
ACCESS PHARMACEUTICALS INC	Nov 2, 2009	BuyD	2.5	10,000.00	$25K	SEC